6.—(1) For the purposes of these Regulations, an individual is treated as having a cleared status (general) only if he or she is and to the extent certified by the Director under this regulation as having a cleared status to enter or remain in any restricted place.
(2) Where the Director or a recognised medical practitioner is satisfied that an individual is a recovered individual, the Director or recognised medical practitioner (as the case may be) may grant a certificate stating that the individual has a cleared status (general) for a period —
(a)
starting the date the recovered individual first tested positive for SARS‑CoV-2 upon undergoing a polymerase chain reaction test (whether before, on or after 24 April 2021); and
(b)
ending on (and including) the 270th day after the date in sub‑paragraph (a).
(3) Where the Director is satisfied that —
(a)
an individual is a recovered individual;
(b)
the individual is vaccinated against a COVID-19 infection by the administration of any approved vaccine by a recognised vaccination provider; and
(c)
14 days or more have elapsed after the day the individual was so vaccinated,
the Director may grant a certificate stating that an individual has a cleared status (general) for a period that starts and ends as stated opposite the approved vaccine in the First Schedule.
(4) In addition, where the Director is satisfied that —
(a)
the individual (who is not a recovered individual) is vaccinated against a COVID‑19 infection by the administration of any approved vaccine by a recognised vaccination provider; and
(b)
14 days or more have elapsed after the day the individual was so vaccinated,
the Director may grant a certificate stating that an individual has a cleared status (general) for a period that starts and ends as stated opposite the approved vaccine in the First Schedule.
Meaning of “cleared status (limited)”
7.—(1) For the purposes of these Regulations, an individual is treated as having a cleared status (limited) only if he or she is and to the extent certified in accordance with this regulation as having a cleared status to enter or remain in any restricted place.
(2) Where the Director or a recognised medical practitioner is satisfied that an individual (who is not a recovered individual) —
(a)
has registered, in person, with an approved test provider to undergo any approved test or tests;
(b)
undergoes the approved test or tests; and
(c)
has met one of the following conditions:
(i)
where the individual undergoes an approved test or tests that do not involve any polymerase chain reaction test — the individual’s test result is negative for SARS‑CoV‑2 after undergoing a relevant sampling activity for the antigen rapid test, or the last antigen rapid test if there are more than one;
(ii)
where the individual undergoes an approved test or tests that involve one or more polymerase chain reaction tests — the individual’s test result is negative for SARS-CoV-2 after undergoing a relevant sampling activity for the polymerase chain reaction test, or the last polymerase chain reaction test if there are more than one,
the Director or recognised medical practitioner (as the case may be) may grant a certificate stating that the individual has a cleared status (limited) —
(d)
starting the time the individual registered, in person, with the approved test provider to undergo the approved test the test result of which shows negative for SARS-CoV-2; and
(e)
ending 24 hours after the time in sub‑paragraph (d).
(3) To avoid doubt, the period in paragraph (2) may be a period before 24 April 2021.
What is negative test result
8.—(1) For the purposes of these Regulations, where an individual undergoes an approved test or tests consisting only of a polymerase chain reaction test or tests, the individual’s test result is treated as negative for SARS-CoV-2 only if —
(a)
the test result from the sole polymerase chain reaction test the individual undergoes shows no presence of SARS‑CoV‑2 in that individual; or
(b)
the test result from the last polymerase chain reaction test the individual undergoes shows no presence of SARS‑CoV‑2 in that individual, after the individual undergoes further polymerase chain reaction tests and the test results of those tests are uncertain or invalid except the last.
(2) For the purposes of these Regulations, where an individual undergoes an approved test or tests consisting only of an antigen rapid test or tests, the individual’s test result is treated as negative for SARS‑CoV‑2 only if —
(a)
the antigen rapid test result from the sole antigen rapid test the individual undergoes shows no presence of SARS‑CoV‑2 in that individual; or
(b)
the test result from the last antigen rapid test the individual undergoes shows no presence of SARS‑CoV‑2 in that individual, after the individual undergoes not more than 2 antigen rapid tests and the test result of one of them is uncertain or invalid.
(3) For the purposes of these Regulations, where an individual undergoes a series of approved tests consisting of polymerase chain reaction tests and antigen rapid tests, the individual’s test result is treated as negative for SARS‑CoV-2 only if —
(a)
the test results of the first and second antigen rapid tests are each uncertain or invalid, another respiratory specimen from the individual is then subjected to a polymerase chain reaction test, and —
(i)
the test result from that polymerase chain reaction test the individual undergoes shows no presence of SARS‑CoV-2 in that individual; or
(ii)
the test result from the last polymerase chain reaction test the individual undergoes shows no presence of SARS-CoV-2 in that individual, after the individual undergoes further polymerase chain reaction tests and the test results of those tests are uncertain or invalid except the last; or
(b)
the test result of an antigen rapid test shows the presence of SARS‑CoV-2 in that individual, another respiratory specimen from the individual is then subjected to a polymerase chain reaction test, and —
(i)
the test result from that polymerase chain reaction test the individual undergoes shows no presence of SARS‑CoV-2 in that individual; or
(ii)
the test result from the last polymerase chain reaction test the individual undergoes shows no presence of SARS‑CoV-2 in that individual, after the individual undergoes further polymerase chain reaction tests and the test results of those tests are uncertain or invalid except the last.
(4) Despite paragraphs (1), (2) and (3), a result of an antigen rapid test for the presence of SARS‑CoV-2 applied to an individual’s respiratory specimen must be disregarded for the purposes of these Regulations if —
(a)
the relevant sampling activity taking the respiratory specimen from the individual was not carried out in Singapore by or under the direction of an approved test provider; or
(b)
the approved test was not carried out by or under the direction of an approved test provider.